Free Trial

Moderna (MRNA) Earnings Date, Estimates & Call Transcripts

$58.03
+1.20 (+2.11%)
(As of 10:47 AM ET)

Earnings Summary

Upcoming
Earnings Date
Nov. 7Estimated
Actual EPS
(Aug. 1)
-$3.33 Beat By $0.14
Consensus EPS
(Aug. 1)
-$3.47
Skip Charts & View Estimated and Actual Earnings Data

MRNA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MRNA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Moderna Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20244($3.49)($1.86)($2.66) 
Q2 20244($3.47)($1.85)($3.02) 
Q3 20244($1.84)$0.10($0.89) 
Q4 20244($1.83)$1.60($0.26) 
FY 202416($10.63)($2.01)($6.82) 
Q1 20251($3.24)($3.24)($3.24) 
Q2 20251($3.39)($3.39)($3.39) 
Q3 20252($1.39)$1.30($0.04) 
Q4 20252($0.71)$1.36$0.33 
FY 20256($8.73)($3.97)($6.35) 
Q1 20261($3.11)($3.11)($3.11) 
Q2 20261($3.10)($3.10)($3.10) 

MRNA Earnings Date and Information

Moderna last issued its quarterly earnings results on August 1st, 2024. The reported ($3.33) earnings per share for the quarter, topping the consensus estimate of ($3.47) by $0.14. The company had revenue of $241 million for the quarter, compared to the consensus estimate of $128.41 million. Its quarterly revenue was down 29.9% compared to the same quarter last year. Moderna has generated ($15.38) earnings per share over the last year (($15.38) diluted earnings per share). Earnings for Moderna are expected to grow in the coming year, from ($9.85) to ($8.59) per share. Moderna has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based off prior year's report dates.

Moderna Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
11/7/2024
(Estimated)
------- 
8/1/2024Q2 2024($3.47)($3.33)+$0.14($3.33)$128.41 million$241.00 million        
5/2/2024Q1 2024($3.59)($3.07)+$0.52($3.07)$93.26 million$167.00 million        
2/22/2024Q4 2023($0.78)$0.55+$1.33$0.55$2.53 billion$2.80 billion        
11/2/2023Q3 2023($2.01)($1.39)+$0.62$6.75$1.37 billion$1.83 billion    
8/3/2023Q2 2023($3.84)($3.62)+$0.22($3.62)$307.67 million$344.00 million        
5/4/2023Q1 2023($1.77)$0.19+$1.96$0.19$1.17 billion$1.86 billion        
2/23/2023Q4 2022$4.66$3.61($1.05)$3.61$5.02 billion$5.08 billion          
11/3/2022Q3 2022$3.04$2.53($0.51)$2.53$3.33 billion$3.36 billion    
8/3/2022Q2 2022$4.50$5.24+$0.74$5.24$3.95 billion$4.73 billion        
5/4/2022Q1 2022$5.18$8.58+$3.40$8.58$4.43 billion$6.07 billion          
2/24/2022Q4 2021$9.83$11.29+$1.46$11.29$6.73 billion$7.21 billion        
11/4/2021Q3 2021$9.49$7.70($1.79)$7.70$6.29 billion$4.97 billion        
8/5/2021Q2 2021$6.01$6.46+$0.45$6.46$4.23 billion$4.35 billion        
5/6/2021Q1 2021$2.04$2.84+$0.80$2.84$2.48 billion$1.94 billion      
2/25/2021Q4 2020($0.25)($0.69)($0.44)($0.69)$279.41 million$570.80 million      
10/29/2020Q3 2020($0.43)($0.59)($0.16)($0.59)$82.50 million$157.90 million      
8/5/2020Q2 2020($0.36)($0.31)+$0.05($0.31)$24.24 million$66.35 million      
5/7/2020Q1 2020($0.37)($0.35)+$0.02($0.35)$18.17 million$8.39 million    
2/26/2020Q4 2019($0.43)($0.37)+$0.06($0.37)$16.86 million$14.06 million    
11/6/2019Q3 2019($0.43)($0.37)+$0.06($0.37)$15.81 million$17.05 million    

Moderna Earnings - Frequently Asked Questions

When is Moderna's earnings date?

Moderna has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based off last year's report dates. Learn more on MRNA's earnings history.

What guidance has Moderna issued on next quarter's earnings?

Moderna issued an update on its FY 2025 earnings guidance on Thursday, September, 12th. The company issued revenue guidance of $2.5 billion-$3.5 billion, compared to the consensus revenue estimate of $3.7 billion.

Did Moderna beat their earnings estimates last quarter?

In the previous quarter, Moderna (NASDAQ:MRNA) reported ($3.33) earnings per share (EPS) to beat the analysts' consensus estimate of ($3.47) by $0.14. Learn more on analysts' earnings estimate vs. MRNA's actual earnings.

How can I listen to Moderna's earnings conference call?

The conference call for Moderna's latest earnings report can be listened to online. Listen to Conference Call

How can I read Moderna's conference call transcript?

The conference call transcript for Moderna's latest earnings report can be read online. Read Transcript

How much revenue does Moderna generate each year?

Moderna (NASDAQ:MRNA) has a recorded annual revenue of $6.85 billion.

How much profit does Moderna generate each year?

Moderna (NASDAQ:MRNA) has a recorded net income of -$4.71 billion. MRNA has generated -$15.38 earnings per share over the last four quarters.

What is Moderna's EPS forecast for next year?

Moderna's earnings are expected to grow from ($9.85) per share to ($8.59) per share in the next year.


More Earnings Resources from MarketBeat


This page (NASDAQ:MRNA) was last updated on 10/11/2024 by MarketBeat.com Staff
From Our Partners